Mark Kawakami insider trades
Open-market stock purchases and sales by Mark Kawakami, Chief Financial Officer at Arcadia Biosciences, Inc, from SEC Form 4 filings since Aug 1, 2024.
Recent trades
No open-market trades in the last 12 months.
Companies traded
- RKDA Arcadia Biosciences, Inc: 2 buys, last May 9, 2025